Clarification on Sputnik V vaccine in the European Medicines Agency approval process

The EMA has to date not received an application for a rolling review or a marketing authorisation for the vaccine developed by the Gamaleya National Centre of Epidemiology and Microbiology in Russia, the Sputnik V vaccine (Gam-COVID-Vac), despite reports stating the opposite.

Source:

European Medicines Agency